BURLINGTON, Vt. & NEW YORK--(BUSINESS WIRE)--Patient Engagement Systems® (PES) and AllazoHealth announced today that they will join together to provide insurers, ACOs, PBMs, integrated delivery networks, and medical groups a suite of tools to better manage patients with chronic conditions. PES and Allazo will bring to their clients the combined benefits of Allazo’s Medication Adherence Prediction technology (AllazoMAP), their individually targeted interventions (AllazoLIFT), and PES’s proven technology for improving outcomes and reducing costs for patients with high cost chronic conditions such as diabetes and chronic kidney disease (CKD).
AllazoHealth’s award-winning technology applies predictive analytics to both anticipate which patients will likely be non-adherent to their medications and then forecasts the most effective medication adherence intervention strategy for each patient. This technology helps patients stay healthy and prevents ER visits and hospital stays.
Stanley Goldstein, president, Patient Engagement Systems, said, “Being successful in the wake of healthcare reform requires all healthcare organizations including ACOs to find ways to improve the health of their patient population while reducing costs. Incorporating patient-physician engagement strategies and clinical decision support with personalized medication adherence intervention strategies will result in achieving better outcomes, lower costs, and increased ROI for our customers.”
Clifford Jones, CEO, AllazoHealth, added, “A medication adherence program’s success is due to the combination of well executed interventions and a predictive and individualized intervention targeting engine that can proactively identify the best interventions to influence individual patients at each point in time.”
About Patient Engagement Systems®
Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health and reduce costs. PES provides medical groups, IPAs, health plans, health systems, and government agencies with a suite of automated patient engagement tools; timely clinical decision support; and the analytics needed to better identify, manage and, monitor these high cost patients. PES’s signature platforms include the Diabetes Patient Engagement System℠, a chronic care management and patient engagement technology developed and tested in a five-year National Institutes of Health funded study that verified care process improvements and cost reductions; the Chronic Kidney Disease Patient Engagement System℠; and the ESRD Prevention Program℠. PES is an IBM Global Entrepreneurial Partner, and is a 2011 URAC Bronze Awardee for Best Practice in Health Care Consumer Empowerment and Protection. www.patientengagementsystems.com
AllazoHealth is an analytics firm focused on predicting patients’ behaviors and predicting how to best influence those behaviors. Allazo provides medication adherence solutions and services to health insurers, PBMs, integrated delivery networks, and ACOs. Combining cutting-edge behavioral science research, medication adherence expertise, and predictive analytics, AllazoHealth is able to forecast patients' adherence to each of their medications and predict the most effective intervention strategies for individual patients. http://www.allazohealth.com